MISSISSAUGA, ON, Jan. 29,
2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH)
(OTCQX: CPHRF) ("Cipher" or "the Company") is
proud to announce that its common shares are now trading on the
OTCQX® Best Market ("OTCQX") under the symbol "CPHRF."
The OTCQX is the highest market tier of OTC Markets on which 12,000
U.S. and global securities trade. Trading on OTCQX will enhance the
visibility and accessibility of the Company to U.S. investors.
Cipher's common shares will continue to trade on the Toronto Stock
Exchange ("TSX") under the symbol "CPH".
"Today's announcement is an important milestone for Cipher. We
have attracted more attention from investors in the United States recently, and our strategy
to trade through a new OTCQX stock quotation will make it easier
for investors in the world's largest capital market to purchase
shares in Cipher.", stated Craig
Mull, Interim Chief Executive Officer.
The OTCQX Market is intended for established, investor-focused
U.S. and international companies. To qualify for OTCQX, companies
must meet prescribed financial standards, follow best practice
corporate governance guidelines, and demonstrate compliance with
applicable securities laws. Trading on the OTCQX Market marks an
important milestone for companies, enabling them to demonstrate
their qualifications and build visibility among U.S. investors.
U.S. investors can find current financial disclosure and trading
statistics, including Real-Time Level 2 quotes, for Cipher on
www.otcmarkets.com.
About Cipher Pharmaceuticals
Inc.
Cipher Pharmaceuticals Inc. (TSX: CPH; OTCQX: CPHRF) is a
specialty pharmaceutical company with a robust and diversified
portfolio of commercial and early to late-stage products. Cipher
acquires products that fulfill unmet medical needs, manages the
required clinical development and regulatory approval process, and
currently markets those products either directly
in Canada or indirectly through partners in Canada,
the U.S. and South America. For more information,
visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.